Middle East and Africa Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

List of Tables

The travel vaccines market in MEA is expected to grow from US$ 120.13 million in 2021 to US$ 167.76 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028.

Continuous demand for life-saving vaccines is the major factor leading to the growth of the travel vaccines market in the region. Vaccines are essential in providing immunity against infectious diseases. Success stories of eradicating smallpox and polio by vaccines inspired many researchers and manufacturing companies. In recent times, vaccines helped control and prevent COVID-19 to a large extent. Moreover, factors such as the growing population, the MEA travel underlying mutations of bacteria and virus, and the development of new threats that require rapid solutions are likely to boost the demand for vaccines and are expected to flourish the market growth during the forecast period.

Despite several manufacturing challenges, vaccine production increased significantly. Technological developments enabled researchers and manufacturing companies to offer potential changes in the formulation, production, and development of vaccines. Also, growing developments in the healthcare industries in developing countries triggered the development and production of vaccines. Such programs are likely to increase the production of vaccines and meet the never-ending demand for immunization in the future.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA travel vaccines market. The MEA travel vaccines market is expected to grow at a good CAGR during the forecast period.

MEA Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

MEA Travel Vaccines Market Segmentation

The MEA travel vaccines market is segmented into product, application, and country. The MEA travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, others segment held the largest share of the market. The MEA travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the MEA travel vaccines market is segmented into Saudi Arabia, South Africa, UAE, and the Rest of the MEA.

Abbott; Bharat Biotech; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA travel vaccines market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025511

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Travel Vaccines Market - By Product
- 1.3.2 MEA Travel Vaccines Market - By Application
- 1.3.3 MEA Travel Vaccines Market - By Country

2. MEA Travel Vaccines Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Travel Vaccines Market- Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion

5. MEA Travel Vaccines Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Significant Rise in Travel and Tourism
- 5.1.2 High Number of Cases of Infectious Diseases
5.2 Market Restraints
- 5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
- 5.3.1 Vaccines Becoming Mandatory
5.4 Future Trends
- 5.4.1 Continuous Demand for Vaccines
5.5 Impact Analysis

6. Travel Vaccines Market - MEA Analysis

6.1 MEA Travel Vaccines Marker Revenue Forecast and Analysis

7. MEA Travel Vaccines Market Analysis - By Product

7.1 Overview
7.2 MEA Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
- 7.3.1 Overview
- 7.3.2 Hepatitis A: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
- 7.4.1 Overview
- 7.4.2 Hepatitis B: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
- 7.5.1 Overview
- 7.5.2 Meningococcal Vaccines: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

8. MEA Travel Vaccines Market Analysis - By Application

8.1 Overview
8.2 MEA Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
- 8.3.1 Overview
- 8.3.2 Domestic Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
- 8.4.1 Overview
- 8.4.2 Outbound Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

9. MEA Travel Vaccines Market - Country Analysis

9.1 Overview
- 9.1.1 MEA: Travel Vaccines Market, by Country, 2020 & 2028 (%)
  - 9.1.1.1 UAE: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.1 UAE: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.2 UAE: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.1.3 UAE: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.2 Saudi Arabia: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.1 Saudi Arabia: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.2 Saudi Arabia: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.2.3 Saudi Arabia: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.3 South Africa: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.1 South Africa: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.2 South Africa: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.3.3 South Africa: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.4 Rest of MEA: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.4.1 Rest of MEA: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.4.2 Rest of MEA: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.4.3 Rest of MEA: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)

10. Travel Vaccines Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
- 10.3.1 Overview
10.4 Inorganic Developments
- 10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Merck & Co., Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Novartis AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Pfizer Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Abbott
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 BHARAT BIOTECH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About the Insight Partners
12.2 Glossary of Terms